{"id":"https://openalex.org/W3210164484","doi":"https://doi.org/10.14309/01.ajg.0000777032.10922.69","title":"S875 The Evolution of Clinical Trial Design in Ulcerative Colitis: Interpreting Future Endpoints Based on Post-Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1","display_name":"S875 The Evolution of Clinical Trial Design in Ulcerative Colitis: Interpreting Future Endpoints Based on Post-Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1","publication_year":2021,"publication_date":"2021-10-01","ids":{"openalex":"https://openalex.org/W3210164484","doi":"https://doi.org/10.14309/01.ajg.0000777032.10922.69","mag":"3210164484"},"language":"en","primary_location":{"id":"doi:10.14309/01.ajg.0000777032.10922.69","doi":"https://doi.org/10.14309/01.ajg.0000777032.10922.69","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0000777032.10922.69","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032150391","display_name":"William J. Sandborn","orcid":"https://orcid.org/0000-0002-3314-7960","observed_orcids":["https://orcid.org/0000-0002-3314-7960"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William J. Sandborn","raw_affiliation_strings":["University of California San Diego, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego, San Diego, CA;","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017140014","display_name":"Bruce E. Sands","orcid":"https://orcid.org/0000-0001-5762-5042","observed_orcids":["https://orcid.org/0000-0001-5762-5042"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce E. Sands","raw_affiliation_strings":["Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY;","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082004256","display_name":"Sharif Uddin","orcid":"https://orcid.org/0000-0002-0268-2178","observed_orcids":["https://orcid.org/0000-0002-0268-2178"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharif Uddin","raw_affiliation_strings":["Takeda Pharmaceuticals USA, Inc., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals USA, Inc., Lexington, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109170529","display_name":"Karen L. Lasch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen Lasch","raw_affiliation_strings":["Takeda Pharmaceuticals USA, Inc., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals USA, Inc., Lexington, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087041151","display_name":"Rana M. Qasim Khan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rana Qasim Khan","raw_affiliation_strings":["Takeda Pharmaceuticals USA, Inc., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals USA, Inc., Lexington, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"116","issue":"1","first_page":"S410","last_page":"S410"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":1.0},{"id":"https://openalex.org/keywords/clinical-trial-endpoints","display_name":"clinical trial endpoints","score":0.8999999761581421},{"id":"https://openalex.org/keywords/mayo-score","display_name":"Mayo score","score":0.7239999771118164},{"id":"https://openalex.org/keywords/physician-s-global-assessment","display_name":"physician global assessment","score":0.7670000195503235},{"id":"https://openalex.org/keywords/modified-mayo-score","display_name":"modified Mayo score","score":0.6710000038146973},{"id":"https://openalex.org/keywords/clinical-remission","display_name":"clinical remission","score":0.8080000281333923},{"id":"https://openalex.org/keywords/vedolizumab","display_name":"vedolizumab","score":0.9440000057220459},{"id":"https://openalex.org/keywords/fda-guidance","display_name":"FDA guidance","score":0.7960000038146973},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C2776207728","wikidata":"https://www.wikidata.org/wiki/Q7918002","display_name":"Vedolizumab","level":4,"score":0.9253190755844116},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.915137529373169},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.7763224840164185},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7601582407951355},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.7521758079528809},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.7506214380264282},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6705166101455688},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5675438642501831},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.5101721286773682},{"id":"https://openalex.org/C2992886853","wikidata":"https://www.wikidata.org/wiki/Q18381816","display_name":"Post hoc","level":2,"score":0.4837903678417206},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.46375492215156555},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.4445223808288574},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.35247188806533813},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32505255937576294},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1116189956665039},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.09076151251792908}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14309/01.ajg.0000777032.10922.69","doi":"https://doi.org/10.14309/01.ajg.0000777032.10922.69","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0000777032.10922.69","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.5,"display_name":"Good health and well-being"},{"id":"https://metadata.un.org/sdg/2","score":0.46000000834465027,"display_name":"Zero hunger"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389903622","https://openalex.org/W4387751120","https://openalex.org/W2031193040","https://openalex.org/W4311280161","https://openalex.org/W1972567972","https://openalex.org/W2579963361","https://openalex.org/W4386817811","https://openalex.org/W2978383550","https://openalex.org/W2979747139","https://openalex.org/W2749627335"],"abstract_inverted_index":{"Introduction:":[0],"Ulcerative":[1],"colitis":[2],"(UC)":[3],"is":[4,22],"a":[5,43,87,113,131,199,273,455,494,591],"chronic,":[6],"relapsing":[7],"disease":[8,49],"characterized":[9],"by":[10],"inflammation":[11],"of":[12,35,48,81,86,117,130,147,154,169,185,201,206,221,231,265,275,282,330,340,374,397,401,457,496],"the":[13,19,53,70,82,141,179,183,219,224,229,258,280,304,323,338,366,372,387,405,577,581],"colon.":[14],"In":[15],"UC":[16,102,214,313,351,574],"clinical":[17,148,188,232,314,377,566,585,588],"trials,":[18,120],"Mayo":[20,30,134,518],"score":[21,32,226,306,519],"used":[23,223,253,348],"to":[24,108,126,198,218,227,246,321,361,395,433,453,492],"assess":[25,228],"outcomes.":[26],"The":[27,286],"12-point":[28],"total":[29],"(t-Mayo)":[31],"incorporates":[33],"measures":[34],"stool":[36,542,613],"frequency,":[37],"rectal":[38,538,609],"bleeding,":[39],"endoscopic":[40,535,606],"findings,":[41],"and":[42,63,73,111,123,163,174,241,268,300,333,357,390,404,445,484,587],"Physician":[44,595,599],"Global":[45,596,600],"Assessment":[46],"(PGA)":[47],"activity.":[50],"However,":[51],"because":[52],"PGA":[54,83,259],"may":[55],"not":[56],"fully":[57],"capture":[58],"improvements":[59],"across":[60],"all":[61],"signs":[62],"symptoms":[64],"associated":[65],"with":[66,140,190,379,525],"UC,":[67,616],"in":[68,84,101,106,150,237,249,349,386,449,488,571],"2016":[69],"US":[71],"Food":[72],"Drug":[74],"Administration":[75],"(FDA)":[76],"issued":[77],"guidance":[78,110,320],"advising":[79],"removal":[80],"favor":[85],"broader":[88],"patient-":[89],"or":[90,239,244,251,459,472,482,498,508,514],"observer-reported":[91],"outcome":[92],"instrument":[93],"for":[94,297,312,565],"future":[95],"trials.1":[96],"We":[97],"examined":[98],"how":[99,128],"endpoints":[100],"trials":[103,153,215,315,352,393],"have":[104,316],"evolved":[105,317],"response":[107,586],"FDA":[109,319],"conducted":[112],"post":[114,166,327],"hoc":[115,167,263,328],"analysis":[116,168,264,329,407],"two":[118],"vedolizumab":[119,191,380,412,421],"GEMINI":[121,172,266,298,331,388],"1":[122,173,267,270,299,302,332,335,389,392,460,470,480,499,506,512,530],"VISIBLE":[124,175,269,301,334,391],"1,":[125,176,354],"understand":[127],"use":[129],"9-point":[132],"modified":[133],"(m-Mayo)":[135],"score,":[136],"excluding":[137],"PGA,":[138],"compares":[139],"t-Mayo":[142,225,305,367],"score.":[143],"Methods:":[144],"Endpoint":[145,310,563],"definitions":[146,205,311,345,355,400,427,564],"remission":[149,189,378,567,589],"phase":[151,572],"3":[152,213,573],"biologic":[155],"maintenance":[156,569],"treatment":[157,570],"were":[158,242],"extracted":[159],"from":[160,171,451,490],"published":[161],"literature":[162],"ClinicalTrials.gov.":[164],"For":[165],"data":[170,271],"we":[177],"measured":[178,342],"difference":[180],"(%\u0394)":[181],"between":[182,371],"proportions":[184],"patients":[186,375],"achieving":[187,376],"versus":[192,381],"placebo":[193,382],"at":[194,383,520],"week":[195,384,521],"52":[196,385,522],"according":[197,394],"range":[200],"four":[202,398],"selected":[203],"endpoint":[204,230,283,344,399,583],"differing":[207,402],"stringency":[208,281,403],"(Figure":[209,307,353],"1).":[210,261,308],"Results:":[211],"Phase":[212],"completed":[216,243,248],"up":[217],"end":[220],"2019":[222],"remission.":[233],"Trials":[234],"that":[235,256,337,362],"began":[236],"2015":[238],"later":[240,252],"estimated":[245],"be":[247],"2020":[250],"m-Mayo":[254],"scores":[255],"excluded":[257],"(Table":[260],"Post":[262],"revealed":[272],"trend":[274],"increasing":[276],"%\u0394":[277,291],"values":[278,292],"as":[279],"definition":[284,289],"decreased.":[285],"second-least":[287],"stringent":[288,436],"produced":[290],"most":[293,431],"like":[294,346],"those":[295,347],"reported":[296,364],"using":[303,343,365],"Conclusion:":[309],"following":[318],"remove":[322],"subjective":[324],"PGA.":[325],"Our":[326],"reveals":[336],"effectiveness":[339],"vedolizumab,":[341],"recent":[350],"C":[356],"D),":[358],"was":[359,584,590],"comparable":[360],"previously":[363],"score.Figure":[368],"1.:":[369,562],"Difference":[370],"proportion":[373],"each":[396],"primary":[406,582],"definition.":[408],"*Patients":[409],"received":[410,419],"intravenous":[411],"once":[413,422],"every":[414,423],"8":[415],"weeks.":[416,425],"\u2020":[417],"Patients":[418],"subcutaneous":[420],"2":[424,524],"\u01c2New":[426],"are":[428],"based":[429],"on":[430],"(A)":[432,438],"least":[434],"(D)":[435,500],"criteria.":[437],"RBS":[439,462,475,501],"=":[440,443,463,466,476,502],"0,":[441,444,464,467,477,503],"ES":[442,465,478,504],"\u2265":[446,485],"1-point":[447,486],"decrease":[448,487],"SFS":[450,468,489,510],"baseline":[452,491],"achieve":[454,493],"subscore":[456,495,528],"0":[458,497],"(B)":[461],"\u2264":[469,479,505,511,523],"(0":[471,481,507,513],"1)":[473,515],"(C)":[474],"1),":[483,509],"(E)":[516],"Total":[517],"no":[526],"individual":[527],">":[529],"CI,":[531],"confidence":[532],"interval;":[533],"ES,":[534,605],"subscore;":[536,540,607,611,615],"RBS,":[537,608],"bleeding":[539,610],"SFS,":[541,612],"frequency":[543,614],"subscore.":[544],"1.":[545],"Feagan":[546],"BG":[547],"et":[548,558],"al.":[549,559],"New":[550],"Engl":[551],"J":[552],"Med":[553],"2013;369:699\u2013710.":[554],"2.":[555],"Sandborn":[556],"WJ":[557],"Gastroenterology":[560],"2020;158:562\u201372Table":[561],"during":[568],"trials.":[575],"*For":[576],"ACT1":[578],"infliximab":[579],"trial,":[580],"secondary":[592],"endpoint.":[593],"\u2020Excludes":[594],"Assessment.":[597,601],"\u01c2Includes":[598],"EBS,":[602],"endoscopy/bleeding/stool":[603],"frequency;":[604],"ulcerative":[617],"colitis.":[618]},"counts_by_year":[],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2021-11-08T00:00:00"}